Skip to content

COVID-19 Dashboard - Created by Dr. Pranav Kumar Mishra and Dr. Shekhar Mishra. doi:10.5281/zenodo.4394299

License

Notifications You must be signed in to change notification settings

pranavmishra90/COVID-19

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Repository files navigation

COVID-19 Dashboard

Pranav Kumar Mishra, MBBS [1] and Shekhar Mishra, Ph.D. [2]

[1] Kasturba Medical College, Manipal; Manipal, KA, India
[2] Discovery Science, Innovation Management; Naperville, IL, USA.

This repository is an automatically updating working paper. It is published by Zenodo and indexed in openAIRE. Latest version: DOI

Dashboard details

Latest update from JHU CSSE COVID-19 Data: Monday, Jan 03, 2022 at 12:00:00 AM

This dashboard file was automatically generated at Tuesday, Jan 04, 2022 at 01:00:27 AM. It took 0:00:15.806939 to run.

Important Numbers

Country # Cases Doubling Time (Days)
US 56190946 88.0
India 34922882 1484.0

Figures

Phase 1 Countries

Figure 1 - Phase 1 Expansion of COVID-19 with Models: We aligned the data from each Phase 1 country, such that t=1 day when the number of cases is closest to, but greater than 100. We include 95% confidence intervals in red, which contain the trajectory of most countries. Disparity is expected near t=1, as countries expand beyond the 100-case cutoff at varying rates. Many reasons exist for early variation in case detection, including, but not limited to, differences in international seeding from China, testing capabilities, healthcare systems, public health policy, including quarantine measures.

Phase 2 BRIAS Countries

Figure 2 - Projection of COVID-19 expansion on Phase 2 BRIAS countries: This group of countries includes the large developing nations of Brazil, Russia, India, and South Africa. We have additionally included Australia as a country of interest, which escaped the initial international expansion of COVID-19.

Doubling Time when crossing 1M cases

Figure 3 - Doubling time at the 1-million case mark: A number of countries have surpassed the 1-million case mark. The rate at which they cross through the mark varies. A 7-day window doubling time was calculated as each of the countries above crossed 1 million cases of COVID-19. A smaller doubling time indicates rapid disease expansion, whereas a longer doubling time indicates slower expansion.

Doubling Time when crossing 5M cases

Figure 4 - Doubling time at the 5-million case mark: A number of countries have surpassed the 5-million case mark. The rate at which they cross through the mark varies. A 7-day window doubling time was calculated as each of the countries above crossed 5 million cases of COVID-19. A smaller doubling time indicates rapid disease expansion, whereas a longer doubling time indicates slower expansion.

Doubling Time when crossing 10M cases

Figure 5 - Doubling time at the 10-million case mark: A number of countries have surpassed the 10-million case mark. The rate at which they cross through the mark varies. A 7-day window doubling time was calculated as each of the countries above crossed 10 million cases of COVID-19. A smaller doubling time indicates rapid disease expansion, whereas a longer doubling time indicates slower expansion.

Doubling Time Histogram

Figure 6 - Distribution of doubling times: As different countries implement different disease mitigation strategies, the rate of expansion within each country varies. A histogram is created of case doubling times, in days, for each country.

License

The content of this project itself is licensed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license, and the underlying source code used to format and display that content is licensed under the MIT license.

Content License

Creative Commons License

COVID-19 Analysis by Pranav Mishra and Shekhar Mishra is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Software License

MIT License - Copyright (c) 2020 Pranav Mishra and Shekhar Mishra